BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang ZK, Yang YS, Chen Y, Yuan J, Sun G, Peng LH. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease. World J Gastroenterol 2014; 20(40): 14805-14820 [PMID: 25356041 DOI: 10.3748/wjg.v20.i40.14805] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Iqbal S, Quigley EMM. Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician. Curr Gastroenterol Rep 2016;18. [DOI: 10.1007/s11894-016-0524-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
2 Cheng Y, Ling Z, Li L. The Intestinal Microbiota and Colorectal Cancer. Front Immunol 2020;11:615056. [PMID: 33329610 DOI: 10.3389/fimmu.2020.615056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
3 Merlini E, Cerrone M, van Wilgenburg B, Swadling L, Cannizzo ES, d'Arminio Monforte A, Klenerman P, Marchetti G. Association Between Impaired Vα7.2+CD161++CD8+ (MAIT) and Vα7.2+CD161-CD8+ T-Cell Populations and Gut Dysbiosis in Chronically HIV- and/or HCV-Infected Patients. Front Microbiol 2019;10:1972. [PMID: 31555223 DOI: 10.3389/fmicb.2019.01972] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
4 Ahlawat S, Kumar P, Mohan H, Goyal S, Sharma KK. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium. Crit Rev Microbiol 2021;47:254-73. [PMID: 33576711 DOI: 10.1080/1040841X.2021.1876631] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Wang JW, Wang YK, Zhang F, Su YC, Wang JY, Wu DC, Hsu WH. Initial experience of fecal microbiota transplantation in gastrointestinal disease: A case series. Kaohsiung J Med Sci. 2019;35:566-571. [PMID: 31197926 DOI: 10.1002/kjm2.12094] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
6 Frei R, Akdis M, O’Mahony L. Prebiotics, probiotics, synbiotics, and the immune system: experimental data and clinical evidence. Curr Opin Gastroenterol. 2015;31:153-158. [PMID: 25594887 DOI: 10.1097/mog.0000000000000151] [Cited by in Crossref: 114] [Cited by in F6Publishing: 63] [Article Influence: 16.3] [Reference Citation Analysis]
7 Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J, Chen ZS. Microbiota in health and diseases. Signal Transduct Target Ther 2022;7:135. [PMID: 35461318 DOI: 10.1038/s41392-022-00974-4] [Reference Citation Analysis]
8 Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther 2016; 7(1): 112-125 [PMID: 26855817 DOI: 10.4292/wjgpt.v7.i1.112] [Cited by in CrossRef: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
9 Bhutiani N, Schucht JE, Miller KR, McClave SA. Technical Aspects of Fecal Microbial Transplantation (FMT). Curr Gastroenterol Rep 2018;20:30. [PMID: 29886561 DOI: 10.1007/s11894-018-0636-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Babickova J, Gardlik R. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11321-11330 [PMID: 26525290 DOI: 10.3748/wjg.v21.i40.11321] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
11 Smolinska S, Groeger D, O'Mahony L. Biology of the Microbiome 1: Interactions with the Host Immune Response. Gastroenterol Clin North Am 2017;46:19-35. [PMID: 28164850 DOI: 10.1016/j.gtc.2016.09.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
12 Xu F, Li N, Wang C, Xing H, Chen D, Wei Y. Clinical efficacy of fecal microbiota transplantation for patients with small intestinal bacterial overgrowth: a randomized, placebo-controlled clinic study. BMC Gastroenterol 2021;21:54. [PMID: 33549047 DOI: 10.1186/s12876-021-01630-x] [Reference Citation Analysis]
13 Jeong YJ, Park HY, Nam HK, Lee KW. Fermented Maillard Reaction Products by Lactobacillus gasseri 4M13 Alters the Intestinal Microbiota and Improves Dysfunction in Type 2 Diabetic Mice with Colitis. Pharmaceuticals (Basel) 2021;14:299. [PMID: 33800583 DOI: 10.3390/ph14040299] [Reference Citation Analysis]
14 Fong W, Li Q, Yu J. Gut microbiota modulation: a novel strategy for prevention and treatment of colorectal cancer. Oncogene. 2020;39:4925-4943. [PMID: 32514151 DOI: 10.1038/s41388-020-1341-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 28.5] [Reference Citation Analysis]
15 Rouhani S, Griffin NW, Yori PP, Gehrig JL, Olortegui MP, Salas MS, Trigoso DR, Moulton LH, Houpt ER, Barratt MJ, Kosek MN, Gordon JI. Diarrhea as a Potential Cause and Consequence of Reduced Gut Microbial Diversity Among Undernourished Children in Peru. Clin Infect Dis 2020;71:989-99. [PMID: 31773127 DOI: 10.1093/cid/ciz905] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
16 Moutinho BD, Baima JP, Rigo FF, Saad-Hossne R, Rodrigues J, Romeiro FG, Sassaki LY. Fecal microbiota transplantation in refractory ulcerative colitis - a case report. J Int Med Res 2019;47:1072-9. [PMID: 30632438 DOI: 10.1177/0300060518821790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Reyes JL, Vannan DT, Eksteen B, Avelar IJ, Rodríguez T, González MI, Mendoza AV. Innate and Adaptive Cell Populations Driving Inflammation in Dry Eye Disease. Mediators Inflamm 2018;2018:2532314. [PMID: 30158831 DOI: 10.1155/2018/2532314] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
18 Lluansí A, Llirós M, Oliver L, Bahí A, Elias-Masiques N, Gonzalez M, Benejam P, Cueva E, Termes M, Ramió-Pujol S, Malagón M, Amoedo J, Serrano M, Busquets D, Torreabla L, Sabat M, Buxó M, Cambra M, Serra-Pagès M, Delgado-Aros S, García-Gil LJ, Elias I, Aldeguer X. In vitro Prebiotic Effect of Bread-Making Process in Inflammatory Bowel Disease Microbiome. Front Microbiol 2021;12:716307. [PMID: 34707578 DOI: 10.3389/fmicb.2021.716307] [Reference Citation Analysis]
19 Zhao JD, Li Y, Sun M, Yu CJ, Li JY, Wang SH, Yang D, Guo CL, Du X, Zhang WJ, Cheng RD, Diao XC, Fang ZH. Effect of berberine on hyperglycaemia and gut microbiota composition in type 2 diabetic Goto-Kakizaki rats. World J Gastroenterol 2021; 27(8): 708-724 [PMID: 33716449 DOI: 10.3748/wjg.v27.i8.708] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
20 Mahdavinia M, Keshavarzian A, Tobin MC, Landay AL, Schleimer RP. A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS). Clin Exp Allergy 2016;46:21-41. [PMID: 26510171 DOI: 10.1111/cea.12666] [Cited by in Crossref: 70] [Cited by in F6Publishing: 65] [Article Influence: 11.7] [Reference Citation Analysis]
21 Fais G, Manca A, Bolognesi F, Borselli M, Concas A, Busutti M, Broggi G, Sanna P, Castillo-aleman YM, Rivero-jiménez RA, Bencomo-hernandez AA, Ventura-carmenate Y, Altea M, Pantaleo A, Gabrielli G, Biglioli F, Cao G, Giannaccare G. Wide Range Applications of Spirulina: From Earth to Space Missions. Marine Drugs 2022;20:299. [DOI: 10.3390/md20050299] [Reference Citation Analysis]
22 Cui HX, Hu YN, Li JW, Yuan K. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Oxid Med Cell Longev. 2018;2018:8930374. [PMID: 30662584 DOI: 10.1155/2018/8930374] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
23 Mertowska P, Mertowski S, Wojnicka J, Korona-Głowniak I, Grywalska E, Błażewicz A, Załuska W. A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects. Nutrients 2021;13:3637. [PMID: 34684638 DOI: 10.3390/nu13103637] [Reference Citation Analysis]
24 de Figueiredo FC, de Barros Ranke FF, de Oliva-neto P. Evaluation of xylooligosaccharides and fructooligosaccharides on digestive enzymes hydrolysis and as a nutrient for different probiotics and Salmonella typhimurium. LWT 2020;118:108761. [DOI: 10.1016/j.lwt.2019.108761] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
25 Cypers H, Bridges SL, Elewaut D. Spondyloarthritis. In: Ragab G, Atkinson TP, Stoll ML, editors. The Microbiome in Rheumatic Diseases and Infection. Cham: Springer International Publishing; 2018. pp. 201-20. [DOI: 10.1007/978-3-319-79026-8_16] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Leshem A, Horesh N, Elinav E. Fecal Microbial Transplantation and Its Potential Application in Cardiometabolic Syndrome. Front Immunol 2019;10:1341. [PMID: 31258528 DOI: 10.3389/fimmu.2019.01341] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
27 Nejadghaderi SA, Nazemalhosseini-Mojarad E, Asadzadeh Aghdaei H. Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy. Med Hypotheses 2021;147:110476. [PMID: 33482620 DOI: 10.1016/j.mehy.2020.110476] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Jia PP, Junaid M, Wen PP, Yang YF, Li WG, Yang XG, Pei DS. Role of germ-free animal models in understanding interactions of gut microbiota to host and environmental health: A special reference to zebrafish. Environ Pollut 2021;279:116925. [PMID: 33744636 DOI: 10.1016/j.envpol.2021.116925] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Choi HH, Cho YS. Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives. Clin Endosc. 2016;49:257-265. [PMID: 26956193 DOI: 10.5946/ce.2015.117] [Cited by in Crossref: 118] [Cited by in F6Publishing: 97] [Article Influence: 19.7] [Reference Citation Analysis]
30 Zhang W, Zou G, Li B, Du X, Sun Z, Sun Y, Jiang X. Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation. J Microbiol Biotechnol 2020;30:1132-41. [PMID: 32423189 DOI: 10.4014/jmb.2002.02044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
31 DeFilippis EM, Longman R, Harbus M, Dannenberg K, Scherl EJ. Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Curr Gastroenterol Rep 2016;18:13. [PMID: 26908281 DOI: 10.1007/s11894-016-0487-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
32 Shi N, Li N, Duan X, Niu H. Interaction between the gut microbiome and mucosal immune system. Mil Med Res. 2017;4:14. [PMID: 28465831 DOI: 10.1186/s40779-017-0122-9] [Cited by in Crossref: 102] [Cited by in F6Publishing: 106] [Article Influence: 20.4] [Reference Citation Analysis]
33 Mahdavinia M. The nasal microbiome: opening new clinical research avenues for allergic disease. Expert Rev Clin Immunol 2018;14:645-7. [PMID: 29999434 DOI: 10.1080/1744666X.2018.1500177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Wei YL, Chen YQ, Gong H, Li N, Wu KQ, Hu W, Wang B, Liu KJ, Wen LZ, Xiao X, Chen DF. Fecal Microbiota Transplantation Ameliorates Experimentally Induced Colitis in Mice by Upregulating AhR. Front Microbiol 2018;9:1921. [PMID: 30197631 DOI: 10.3389/fmicb.2018.01921] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
35 Wang L, Zhou J, Gober HJ, Leung WT, Huang Z, Pan X, Li C, Zhang N, Wang L. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype. Biomed Pharmacother. 2021;133:110958. [PMID: 33171400 DOI: 10.1016/j.biopha.2020.110958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
36 Jin B. Fecal microbiota transplantation in ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2017; 25(1): 23-30 [DOI: 10.11569/wcjd.v25.i1.23] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Effinger A, O'driscoll CM, Mcallister M, Fotaki N. Impact of gastrointestinal disease states on oral drug absorption – implications for formulation design – a PEARRL review. Journal of Pharmacy and Pharmacology 2019;71:674-98. [DOI: 10.1111/jphp.12928] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
38 Cui X, Zhang H, Du H. Carbapenemases in Enterobacteriaceae: Detection and Antimicrobial Therapy. Front Microbiol 2019;10:1823. [PMID: 31481937 DOI: 10.3389/fmicb.2019.01823] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
39 Fiebiger U, Bereswill S, Heimesaat MM. Dissecting the Interplay Between Intestinal Microbiota and Host Immunity in Health and Disease: Lessons Learned from Germfree and Gnotobiotic Animal Models. Eur J Microbiol Immunol (Bp) 2016;6:253-71. [PMID: 27980855 DOI: 10.1556/1886.2016.00036] [Cited by in Crossref: 67] [Cited by in F6Publishing: 68] [Article Influence: 11.2] [Reference Citation Analysis]
40 Wang Y, Ren R, Sun G, Peng L, Tian Y, Yang Y. Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. Int Immunopharmacol 2020;85:106661. [PMID: 32563025 DOI: 10.1016/j.intimp.2020.106661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
41 Hsu WH, Wang JY, Kuo CH. Current applications of fecal microbiota transplantation in intestinal disorders. Kaohsiung J Med Sci 2019;35:327-31. [PMID: 31017741 DOI: 10.1002/kjm2.12069] [Reference Citation Analysis]
42 Sinagoga KL, Wells JM. Generating human intestinal tissues from pluripotent stem cells to study development and disease. EMBO J 2015;34:1149-63. [PMID: 25792515 DOI: 10.15252/embj.201490686] [Cited by in Crossref: 63] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
43 Ren RR, Sun G, Yang YS, Peng LH, Wang SF, Shi XH, Zhao JQ, Ban YL, Pan F, Wang XH, Lu W, Ren JL, Song Y, Wang JB, Lu QM, Bai WY, Wu XP, Wang ZK, Zhang XM, Chen Y. Chinese physicians’ perceptions of fecal microbiota transplantation. World J Gastroenterol 2016; 22(19): 4757-4765 [PMID: 27217707 DOI: 10.3748/wjg.v22.i19.4757] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
44 Cassard AM, Gérard P, Perlemuter G. Microbiota, Liver Diseases, and Alcohol. Microbiol Spectr 2017;5. [PMID: 28840806 DOI: 10.1128/microbiolspec.BAD-0007-2016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
45 Hermes GDA, Reijnders D, Kootte RS, Goossens GH, Smidt H, Nieuwdorp M, Blaak EE, Zoetendal EG. Individual and cohort-specific gut microbiota patterns associated with tissue-specific insulin sensitivity in overweight and obese males. Sci Rep 2020;10:7523. [PMID: 32371932 DOI: 10.1038/s41598-020-64574-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Bak SH, Choi HH, Lee J, Kim MH, Lee YH, Kim JS, Cho YS. Fecal microbiota transplantation for refractory Crohn's disease. Intest Res. 2017;15:244-248. [PMID: 28522956 DOI: 10.5217/ir.2017.15.2.244] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
47 Liu Y, Zhao J, Zhao Y, Zong S, Tian Y, Chen S, Li M, Liu H, Zhang Q, Jing X, Sun B, Wang H, Sun T, Yang C. Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer. J Cell Mol Med 2019;23:750-60. [PMID: 30472806 DOI: 10.1111/jcmm.13897] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
48 Finamore A, Palmery M, Bensehaila S, Peluso I. Antioxidant, Immunomodulating, and Microbial-Modulating Activities of the Sustainable and Ecofriendly Spirulina. Oxid Med Cell Longev 2017;2017:3247528. [PMID: 28182098 DOI: 10.1155/2017/3247528] [Cited by in Crossref: 44] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
49 Sivignon A, Bouckaert J, Bernard J, Gouin SG, Barnich N. The potential of FimH as a novel therapeutic target for the treatment of Crohn’s disease. Expert Opinion on Therapeutic Targets 2017;21:837-47. [DOI: 10.1080/14728222.2017.1363184] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
50 Potter RF, D'Souza AW, Dantas G. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat 2016;29:30-46. [PMID: 27912842 DOI: 10.1016/j.drup.2016.09.002] [Cited by in Crossref: 143] [Cited by in F6Publishing: 127] [Article Influence: 23.8] [Reference Citation Analysis]
51 Tu Y, Yang R, Xu X, Zhou X. The microbiota-gut-bone axis and bone health. J Leukoc Biol 2021;110:525-37. [PMID: 33884666 DOI: 10.1002/JLB.3MR0321-755R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Chen R, Liu B, Wang X, Chen K, Zhang K, Zhang L, Fei C, Wang C, Yingchun L, Xue F, Gu F, Wang M. Effects of polysaccharide from Pueraria lobata on gut microbiota in mice. Int J Biol Macromol 2020:S0141-8130(20)33067-1. [PMID: 32387359 DOI: 10.1016/j.ijbiomac.2020.04.201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
53 Cresci GA, Bawden E. Gut Microbiome: What We Do and Don't Know. Nutr Clin Pract 2015;30:734-46. [PMID: 26449893 DOI: 10.1177/0884533615609899] [Cited by in Crossref: 106] [Cited by in F6Publishing: 95] [Article Influence: 15.1] [Reference Citation Analysis]
54 Emília H, Izabela B, Jana Š, Ladislav S, Anna C, Alojz B. Anti-inflammatory potential of Lactobacillus plantarum LS/07 in acute colitis in rats. Acta Veterinaria 2018;68:55-64. [DOI: 10.2478/acve-2018-0005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Lucas López R, Grande Burgos MJ, Gálvez A, Pérez Pulido R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. APMIS 2017;125:3-10. [PMID: 27704622 DOI: 10.1111/apm.12609] [Cited by in F6Publishing: 43] [Reference Citation Analysis]
56 Xu P, Lv T, Dong S, Cui Z, Luo X, Jia B, Jeon CO, Zhang J. Association between intestinal microbiome and inflammatory bowel disease: insights from bibliometric analysis. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.04.006] [Reference Citation Analysis]
57 Ramai D, Zakhia K, Ofosu A, Ofori E, Reddy M. Fecal microbiota transplantation: donor relation, fresh or frozen, delivery methods, cost-effectiveness. Ann Gastroenterol 2019;32:30-8. [PMID: 30598589 DOI: 10.20524/aog.2018.0328] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]